Inhibikase Therapeutics’s (IKT) 20-Day exponential moving average is 2.88, while Inhibikase Therapeutics’s (IKT) share price is $2.8, making it a Sell.

Inhibikase Therapeutics’s (IKT) 50-Day exponential moving average is 2.80, while Inhibikase Therapeutics’s (IKT) share price is $2.8, making it a Sell.

Advanced Chart >

Inhibikase Therapeutics (IKT) Pivot Points

Jan 31, 2025, 07:24 AM

Classic

2.57

2.61

2.69

2.73

2.81

2.85

2.93

Fibonacci

2.61

2.66

2.69

2.73

2.78

2.81

2.85

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Inhibikase Therapeutics (IKT) Moving Averages

Jan 31, 2025, 07:24 AM

MA5

2.79Buy

2.78Buy

MA10

2.78Buy

2.81Sell

MA20

2.93Sell

2.88Sell

MA50

2.88Sell

2.80Sell

MA100

2.34Buy

2.52Buy

MA200

1.93Buy

2.22Buy

Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 2.81, while Inhibikase Therapeutics’s (IKT) share price is $2.8, making it a Sell.

Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 2.52, while Inhibikase Therapeutics’s (IKT) share price is $2.8, making it a Buy.

Inhibikase Therapeutics’s (IKT) stock price is $2.8 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 2.88, creating a Sell signal.

Inhibikase Therapeutics’s (IKT) stock price is $2.8 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 2.34, creating a Buy signal.

Inhibikase Therapeutics’s (IKT) stock price is $2.8 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 1.93, creating a Buy signal.

Inhibikase Therapeutics (IKT) Technical Indicators

Jan 31, 2025, 07:24 AM

RSI (14)

45.76

Neutral

STOCH (9,6)

52.13

Neutral

STOCHRSI (14)

26.17

Neutral

MACD (12,26)

-0.07

Buy

ADX (14)

18.31

Buy

Williams %R

-68.55

Buy

CCI (14)

-50.56

Neutral

ATR (14)

0.26

Ultimate Oscillator

50.31

Neutral

ROC

-12.77

Sell

Inhibikase Therapeutics’s (IKT) Relative Strength Index (RSI) is 45.76, creating a Neutral signal.

Inhibikase Therapeutics’s (IKT) Trend Strength Indicator (ADX) is 18.31, creating a Buy signal.

Inhibikase Therapeutics’s (IKT) Commodity Channel Index (CCI) is -50.56, creating a Neutral signal.

Inhibikase Therapeutics’s (IKT) Price Rate of Change (ROC) is -12.77, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is IKT a Buy, Hold, or Sell?

Based on IKT’s technical indicators, IKT is a Buy.

What is IKT’s RSI (14)?

IKT’s RSI (14) is 45.76, which suggests IKT is a Neutral.

What is IKT’s MACD?

IKT’s MACD is -0.07, which suggests IKT is a Buy.

What is IKT’s 5-day moving average?

IKT’s 5-day moving average is 2.79, which suggests IKT is a Buy.

What is IKT’s 20-day moving average?

IKT 20-day moving average is 2.93, which suggests IKT is a Sell.

What is IKT’s 50-day moving average?

IKT’s 50-day moving average is 2.88, which suggests IKT is a Sell.

What is IKT’s 200-day moving average?

IKT’s 200-day moving average is 1.93, which suggests IKT is a Buy.

What is IKT’s Williams % R (14)?

IKT’s Williams % R (14) is -68.55, which suggests IKT is a Buy.

What is IKT’s CCI (14)?

IKT’s CCI (14) is -50.56, which suggests IKT is a Neutral.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing